Support program for vulnerable people with lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a “navigation” support program to improve survival and quality of life for people with non-small cell lung cancer who are considered vulnerable. It may help you get the right care and support more smoothly throughout treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have been diagnosed with non-small cell lung cancer (NSCLC), at any stage
- You can get around and do daily activities fairly well (performance status 2 or less)
- You meet the trial’s definition of “vulnerable” based on their set criteria
- You can receive the study’s treatment/support
- You can read and understand Danish
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a program to help people at high risk for certain cancers get the free screening tests they need. It aims to make screening easier by providing personalized guidance in the community.
This trial studies whether regularly reporting symptoms on a website helps predict (and possibly improve) outcomes for people with advanced lung cancer. It compares survival-related information using these web symptom reports alongside usual cancer treatment.
This trial tests whether a special navigation system during lung cancer surgery (using SERS technology) can help surgeons better locate and remove lung tumor tissue. You may be able to take part if you are having surgery to remove the tumor and meet the study’s timing and health requirements.
This trial tests a cross-sector rehabilitation program for people with non-small cell lung cancer (the most common type of lung cancer) who are starting their first cancer treatment. The goal is to see if this program helps you recover and feel better during and after treatment.
This is an observational study that collects real-world information from adults with lung cancer or breast cancer. It may help doctors better understand how people do over time and how treatments and outcomes relate to details from your medical record and tests.
This study tests whether having a trained lay navigator (a non-medical person who guides you through cancer care) helps lung cancer patients better understand their treatment and manage their care. The navigator helps answer questions, arrange appointments, and connect you with resources.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.